Top 10 Low Price Stocks To Buy Right Now

Top 10 Low Price Stocks To Buy Right Now: Jazz Pharmaceuticals Inc.(JAZZ)

Jazz Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the identification, development, and commercialization of pharmaceutical products to meet unmet medical needs. The company markets Xyrem, a sodium oxybate oral solution for the treatment of both cataplexy and excessive daytime sleepiness in patients with narcolepsy; and Luvox CR extended-release capsules for the treatment of obsessive compulsive disorder. Its product candidates under clinical development include JZP-6, a Phase III pivotal clinical trials completed product for the treatment of fibromyalgia; and JZP-8, an intranasal formulation of clonazepam, which has completed Phase II clinical trial for the treatment of acute repetitive seizures in epilepsy and solid oral dosage forms of sodium oxybate. The company sells its products through specialty sales force targeting sleep specialists, psychiatrists, neurologists, and pulmonologists. Jazz Pharmaceuticals, Inc. was founded in 2003 and is headq uartered in Palo Alto, California.

Advisors' Opinion:

• [By Michael Robinson]

  Jazz Pharmaceuticals PLC (JAZZ) has a strong expertise in treating narcolepsy, chronic pain, blood disease, cancer, and some psychiatric disorders.

• [By Myra Ramdenbourg]

  Jazz Pharmaceuticals PLC (JAZZ): EVP and CFO Kathryn E. Falberg Sold 2,000 Shares

  On 02/12/2014, EVP and CFO Kathryn E. Falberg sold 2,000 shares at an average price of $157. The price of the stock has decreased by 1.12% since. Jazz Pharmaceuticals PLC has a market cap of $9.01 billion and its shares were traded at around $155.24. The company has a P/E ratio of 44.00 and P/S ratio of 10.96. Over the past five years, Jazz Pharmaceuticals PLC had an annual average earnings growth of 68.30%.

source from Top Stocks Blog:http://www.topstocksblog.com/top-10-low-price-stocks-to-buy-right-now.html